Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML

Leukemia(2021)10.1038/s41375-021-01393-0Source: DataRank Database

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML is a research paper published in Leukemia (2021). On theSindex it has a DataRank of 0.631. It has been cited 66 times.

N/A

0.631DataRank · unranked

Scored on demand from live citation data

Open Access66 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 5.38)OA: hybridTopics (69)Linked Datasets (18)DataCite Reuse (18)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.631

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (22)

Tina M. Schnoeder ORCID,Yijun Xiong ORCID,Ashok Kumar Jayavelu ORCID,Nomusa Mashamba,Nuria Tubío Santamaría

Live enrichment

PubMed:34465866 PMC:PMC8807392 OpenAlex:https://openalex.org/W3198529911

European Hematology Association

Grant: TRTH64

NCI NIH HHS

Grant: P50 CA206963

NCI NIH HHS

Grant: R01 CA176745

NCI NIH HHS

Grant: P01 CA066996

NCI NIH HHS

Grant: R01 CA204639

National Institutes of Health

Grant: 7R01CA176745-02

Targeting to Epigenetic Modications in ALL

National Institutes of Health

Grant: 7P50CA206963-03

SPORE in Myeloid Malignancies

National Institutes of Health

Grant: 5R01CA204639-02

Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies

National Institutes of Health

Grant: 1P01CA066996-03

BIOLOGICAL HETEROGENEITY OF AGGRESSIVE NONHODGKINS LYMPHOMA

FWCI

5.38

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://www.nature.com/articles/s41375-021-01393-0.pdf

publisherhttps://www.nature.com/articles/s41375-021-01393-0.pdf

publisherhttps://www.nature.com/articles/s41375-021-01393-0

journalhttps://doi.org/10.1038/s41375-021-01393-0

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34465866

Fields of Study

Acute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentRNA Research and Splicing0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsApoptosisBiomarkers, TumorCell CompetitionCell ProliferationHumansJanus Kinase 2Leukemia, Myeloid, AcuteMiceMutationPrognosisProto-Oncogene Proteins c-mycTumor Cells, CulturedXenograft Model Antitumor AssaysY-Box-Binding Protein 1

MeSH Terms

Cell CompetitionAnimalsHumansMutationPrognosisTumor Cells, CulturedBiomarkers, TumorLeukemia, Myeloid, AcuteProto-Oncogene Proteins c-mycApoptosisXenograft Model Antitumor AssaysCell ProliferationMiceY-Box-Binding Protein 1Janus Kinase 2

Keywords

BiologyMyeloid leukemiaLeukemiaCancer researchMinimal residual diseaseTranslation (biology)MyeloidMediatorCell growthImmunologyCell biologyGeneMessenger RNAGeneticsddc:610610ApoptosisJanus Kinase 2PrognosisXenograft Model Antitumor AssaysArticleProto-Oncogene Proteins c-mycLeukemia, Myeloid, AcuteMiceCell CompetitionMutationBiomarkers, TumorTumor Cells, CulturedAnimalsHumansY-Box-Binding Protein 1info:eu-repo/classification/ddc/610Cell Proliferation

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 5 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792838figshare

Additional file 2 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792829figshare

Additional file 1 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792826figshare

Additional file 9 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792853.v1figshare

Additional file 3 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792832figshare

Additional file 6 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792841.v1figshare

Additional file 2 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792829.v1figshare

Additional file 8 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792850.v1figshare

Additional file 4 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792835figshare

Additional file 8 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792850figshare

Additional file 4 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792835.v1figshare

Additional file 7 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792847.v1figshare

Additional file 5 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792838.v1figshare

Additional file 7 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792847figshare

Additional file 9 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792853figshare

Additional file 1 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792826.v1figshare

Additional file 3 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792832.v1figshare

Additional file 6 of Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer

10.6084/m9.figshare.22792841figshare

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML

FAIR Checklist

DataRank Breakdown

Authors (22)

Funding (9 grants)

Impact

Open Access

Topics

Linked Datasets (18)

Annotations (Europe PMC)